TPST
Price:
$0.9498
Market Cap:
$25.23M
Tempest Therapeutics Inc., a clinical-stage oncology company, engages in developing small molecule therapeutics to treat cancer. The company's two clinical programs are TPST-1495, a dual antagonist of EP2 and EP4, receptors of prostaglandin E2, and is currently in a Phase 1 trial in solid tumors; and TPST-1120, a selective antagonist of peroxisome proliferator-activated receptor alpha that is in a Phase 1 trial in solid tumors. It also develops TREX-1, a key cellular enzyme that regulates the innate immune response in tumors. The company was founded in 2011 and is headquartered in South San Francisco, California. Tempest Therapeutics Inc. was formerly a subsidiary of Inception Sciences, Inc.[Read more]
Industry
Biotechnology
IPO Date
2012-11-12
Stock Exchange
NASDAQ
Ticker
TPST
According to Tempest Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Dividend Yield is 0%. This represents a change of 0% compared to the average of 0% of the last 4 quarters.
The mean historical Dividend Yield of Tempest Therapeutics, Inc. over the last ten years is 0%. The current 0% Dividend Yield has changed 0% with respect to the historical average. Over the past ten years (40 quarters), TPST's Dividend Yield was at its highest in in the September 2014 quarter at 0%. The Dividend Yield was at its lowest in in the September 2014 quarter at 0%.
Average
0%
Median
0%
Minimum
0%
Maximum
0%
Discovering the peaks and valleys of Tempest Therapeutics, Inc. Dividend Yield, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual Dividend Yield = 0%
Minimum Annual Increase = 0%
Minimum Annual Dividend Yield = 0%
Year | Dividend Yield | Change |
---|---|---|
2023 | 0% | 0% |
2022 | 0% | 0% |
2021 | 0% | 0% |
2020 | 0% | 0% |
2019 | 0% | 0% |
2018 | 0% | 0% |
2017 | 0% | 0% |
2016 | 0% | 0% |
2015 | 0% | 0% |
2014 | 0% | 0% |
The current Dividend Yield of Tempest Therapeutics, Inc. (TPST) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
0%
5-year avg
0%
10-year avg
0%
Tempest Therapeutics, Inc.’s Dividend Yield is less than Indaptus Therapeutics, Inc. (0%), less than Rezolute, Inc. (0%), less than Comera Life Sciences Holdings, Inc. (0%), less than Forte Biosciences, Inc. (0%), less than Sana Biotechnology, Inc. (0%), less than Olema Pharmaceuticals, Inc. (0%), less than Cullinan Oncology, Inc. (0%), less than aTyr Pharma, Inc. (0%), less than Zentalis Pharmaceuticals, Inc. (0%), less than Lyell Immunopharma, Inc. (0%), less than Monte Rosa Therapeutics, Inc. (0%), less than Theseus Pharmaceuticals, Inc. (0%), less than Revolution Medicines, Inc. (0%), less than ZIVO Bioscience, Inc. (0%), less than RenovoRx, Inc. (0%), less than Ikena Oncology, Inc. (0%), less than Catalyst Biosciences, Inc. (0%), less than Akari Therapeutics, Plc (0%), less than Armata Pharmaceuticals, Inc. (0%), less than Anebulo Pharmaceuticals, Inc. (0%), less than Scopus BioPharma Inc. (0%), less than Processa Pharmaceuticals, Inc. (0%),
Company | Dividend Yield | Market cap |
---|---|---|
0% | $12.03M | |
0% | $304.25M | |
0% | $3.07K | |
0% | $6.49M | |
0% | $839.81M | |
0% | $680.32M | |
0% | $923.57M | |
0% | $131.12M | |
0% | $267.44M | |
0% | $325.12M | |
0% | $543.76M | |
0% | $181.50M | |
0% | $9.33B | |
0% | $68.94M | |
0% | $24.47M | |
0% | $82.52M | |
0% | $19.42M | |
0% | $28.90M | |
0% | $86.12M | |
0% | $49.01M | |
0% | $16.83K | |
0% | $3.63M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Tempest Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Tempest Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Dividend Yield?
How can you use the Dividend Yield?
What is Tempest Therapeutics, Inc.'s Dividend Yield?
How is the Dividend Yield calculated for Tempest Therapeutics, Inc. (TPST)?
What is the highest Dividend Yield for Tempest Therapeutics, Inc. (TPST)?
What is the 3-year average Dividend Yield for Tempest Therapeutics, Inc. (TPST)?
What is the 5-year average Dividend Yield for Tempest Therapeutics, Inc. (TPST)?
How does the current Dividend Yield for Tempest Therapeutics, Inc. (TPST) compare to its historical average?